Determinants of homocysteine levels in colorectal and breast cancer patients

Patrizia Ferroni, R. Palmirotta, F. Martini, S. Riondino, A. Savonarola, A. Spila, F. Ciatti, V. Sini, S. Mariotti, G. Del Monte, M. Roselli, F. Guadagni

Research output: Contribution to journalArticlepeer-review


Background: Homocysteinemia has been associated with oncogenic risk. This study was designed to investigate the homocysteine (Hcy) genotypelphenotype interactions together with the inflammatory and nutritional status of cancer patients. Patients and Methods: The Hcy levels were analyzed in 47 cancer patients in association with methylenetetrahydrofolate reductase (MTHFR) polymorphisms, folate and inflammatory markers. Results: The MTHFR C677T and A1298C genotype distributions did not differ from those predicted by the Hardy-Weinberg distribution. Conversely, the Hcy levels were higher in the cancer patients (p=0.04), who were also characterized by low-grade inflammation. The Hcy levels correlated with the interleukin-6 (IL-6) (p=0.001), tumor necrosis factor-a (TNF-a) (p=0.042) and folate (p

Original languageEnglish
Pages (from-to)4131-4138
Number of pages8
JournalAnticancer Research
Issue number10
Publication statusPublished - Oct 2009


  • Breast cancer
  • Colorectal cancer
  • Homocysteinemia
  • Inflammation

ASJC Scopus subject areas

  • Cancer Research
  • Oncology


Dive into the research topics of 'Determinants of homocysteine levels in colorectal and breast cancer patients'. Together they form a unique fingerprint.

Cite this